CCO Treatment Updates

Metastatic Colorectal Cancer: Expert Guidance on Selection of First-line Therapy

Interactive Virtual Presentation

Expert Insight Into the First-line Treatment of Metastatic Colorectal Cancer

Program Director: Steven R. Alberts, MD

Faculty:

Edward Chu, MD

CREDIT INFORMATION

Release Date: 4/1/11

Expiration Date: 3/31/12

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: The activity is not currently available for credit.

Edward Chu, MD, discusses and demonstrates, through the use of case scenarios, how patient characteristics play an important role in making first-line treatment decisions for patients with metastatic colorectal cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

Assess how a patient’s characteristics influence the choice of treatment for metastatic colorectal cancer
Determine how KRAS status plays an important role as a biomarker for selecting treatment options for patients with metastatic colorectal cancer
Assess the advantages and disadvantages of specific chemotherapy regimens for the first-line treatment of patients with metastatic colorectal cancer
Choose the optimal targeted therapy to combine with chemotherapy for the first-line treatment of patients with metastatic colorectal cancer

Slideset: Expert Insight Into the First-line Treatment of Metastatic Colorectal Cancer

Download slides focused on how patient characteristics play an important role in making first-line treatment decisions for patients with metastatic colorectal cancer.

Format: Microsoft PowerPoint (.ppt) | File size: 1.10 MB | Date posted: 4/1/2011

Interactive Tool

First-Line Treatment of mCRC

With just a few clicks through pull-down menus, use this Interactive Decision Support Tool to enter your patient’s specific characteristics along with the treatment options you would likely choose for the first-line treatment of colorectal cancer. Then view the preferred choices of 5 colorectal cancer experts via a graphical Expert Insight display and assess if the expert choices affect your own decision making.

Format: HTML | Date posted: 4/15/2011

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.